Export 21 results:
Author Title Type [ Year(Asc)]
Filters: Author is VanVeldhuisen, Paul  [Clear All Filters]
2021
T. Etheridge, Dobson, E. T. A., Wiedenmann, M., Oden, N., VanVeldhuisen, P., Scott, I. U., Ip, M. S., Eliceiri, K. W., Blodi, B. A., and Domalpally, A., “Ellipsoid Zone Defects in Retinal Vein Occlusion Correlates With Visual Acuity Prognosis: SCORE2 Report 14.”, Transl Vis Sci Technol, vol. 10, no. 3, p. 31, 2021.
S. Whittier, Au, A., Sarraf, D., Oden, N., VanVeldhuisen, P., Scott, I., Ip, M., Watson, S., Blodi, B., and Domalpally, A., “Reproducibility of Grading Superficial vs Deep Retinal Hemorrhage in the Study of COmparative Treatments for REtinal Vein Occlusion 2 (SCORE2)”, in Association for Research in Vision and Ophthalmology Annual Meeting, 2021.
2020
L. Hu, Oden, N., Tai, B., and VanVeldhuisen, P., “Prevalence of obesity among U.S. population with substance dependence.”, Drug Alcohol Depend, vol. 217, p. 108293, 2020.
2019
G. D'Onofrio, E Edelman, J., Hawk, K. F., Pantalon, M. V., Chawarski, M. C., Owens, P. H., Martel, S. H., VanVeldhuisen, P., Oden, N., Murphy, S. M., Huntley, K., O'Connor, P. G., and Fiellin, D. A., “Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).”, Implement Sci, vol. 14, no. 1, p. 48, 2019.
2018
C. I. Campbell, Bahorik, A. L., VanVeldhuisen, P., Weisner, C., Rubinstein, A. L., and G Ray, T., “Use of a prescription opioid registry to examine opioid misuse and overdose in an integrated health system.”, Prev Med, vol. 110, pp. 31-37, 2018.
2017
Y. Mao, Wu, Z., McGoogan, J. M., Liu, D., Gu, D., Erinoff, L., Ling, W., VanVeldhuisen, P., Detels, R., Hasson, A. L., Lindblad, R., Montaner, J. S. G., Tang, Z., and Zhao, Y., “Care cascade structural intervention versus standard of care in the diagnosis and treatment of HIV in China: a cluster-randomized controlled trial protocol.”, BMC Health Serv Res, vol. 17, no. 1, p. 397, 2017.
L. - T. Wu, McNeely, J., Subramaniam, G. A., Brady, K. T., Sharma, G., VanVeldhuisen, P., Zhu, H., and Schwartz, R. P., “DSM-5 substance use disorders among adult primary care patients: Results from a multisite study.”, Drug Alcohol Depend, vol. 179, pp. 42-46, 2017.
2016
L. - T. Wu, McNeely, J., Subramaniam, G. A., Sharma, G., VanVeldhuisen, P., and Schwartz, R. P., “Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool.”, Contemp Clin Trials, vol. 50, pp. 90-7, 2016.
L. R. Metsch, Feaster, D. J., Gooden, L., Matheson, T., Stitzer, M., Das, M., Jain, M. K., Rodriguez, A. E., Armstrong, W. S., Lucas, G. M., Nijhawan, A. E., Drainoni, M. - L., Herrera, P., Vergara-Rodriguez, P., Jacobson, J. M., Mugavero, M. J., Sullivan, M., Daar, E. S., McMahon, D. K., Ferris, D. C., Lindblad, R., VanVeldhuisen, P., Oden, N., Castellón, P. C., Tross, S., Haynes, L. F., Douaihy, A., Sorensen, J. L., Metzger, D. S., Mandler, R. N., Colfax, G. N., and del Rio, C., “Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial.”, JAMA, vol. 316, no. 2, pp. 156-70, 2016.
L. - T. Wu, Brady, K. T., Spratt, S. E., Dunham, A. A., Heidenfelder, B., Batch, B. C., Lindblad, R., VanVeldhuisen, P., Rusincovitch, S. A., Killeen, T. K., and Ghitza, U. E., “Using electronic health record data for substance use Screening, Brief Intervention, and Referral to Treatment among adults with type 2 diabetes: Design of a National Drug Abuse Treatment Clinical Trials Network study.”, Contemp Clin Trials, vol. 46, pp. 30-38, 2016.
2014
T. M. Winhusen, Kropp, F., Lindblad, R., Douaihy, A., Haynes, L., Hodgkins, C., Chartier, K., Kampman, K. M., Sharma, G., Lewis, D. F., VanVeldhuisen, P., Theobald, J., May, J., and Brigham, G. S., “Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence.”, J Clin Psychiatry, vol. 75, no. 7, pp. 757-64, 2014.
B. Tai, Hu, L., Ghitza, U. E., Sparenborg, S., VanVeldhuisen, P., and Lindblad, R., “Patient registries for substance use disorders.”, Subst Abuse Rehabil, vol. 5, pp. 81-6, 2014.
2013
D. Shmueli-Blumberg, Hu, L., Allen, C., Frasketi, M., Wu, L. - T., and VanVeldhuisen, P., “The national drug abuse treatment clinical trials network data share project: website design, usage, challenges, and future directions.”, Clin Trials, vol. 10, no. 6, pp. 977-86, 2013.
2012
J. L. Wiggs, Yaspan, B. L., Hauser, M. A., Kang, J. H., R Allingham, R., Olson, L. M., Abdrabou, W., Fan, B. J., Wang, D. Y., Brodeur, W., Budenz, D. L., Caprioli, J., Crenshaw, A., Crooks, K., Delbono, E., Doheny, K. F., Friedman, D. S., Gaasterland, D., Gaasterland, T., Laurie, C., Lee, R. K., Lichter, P. R., Loomis, S., Liu, Y., Medeiros, F. A., McCarty, C., Mirel, D., Moroi, S. E., Musch, D. C., Realini, A., Rozsa, F. W., Schuman, J. S., Scott, K., Singh, K., Stein, J. D., Trager, E. H., VanVeldhuisen, P., Vollrath, D., Wollstein, G., Yoneyama, S., Zhang, K., Weinreb, R. N., Ernst, J., Kellis, M., Masuda, T., Zack, D., Richards, J. E., Pericak-Vance, M., Pasquale, L. R., and Haines, J. L., “Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma.”, PLoS Genet, vol. 8, no. 4, p. e1002654, 2012.
A. N. C. Campbell, Nunes, E. V., Miele, G. M., Matthews, A., Polsky, D., Ghitza, U. E., Turrigiano, E., Bailey, G. L., VanVeldhuisen, P., Chapdelaine, R., Froias, A., Stitzer, M. L., Carroll, K. M., Winhusen, T., Clingerman, S., Perez, L., McClure, E., Goldman, B., and A Crowell, R., “Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network.”, Contemp Clin Trials, vol. 33, no. 2, pp. 386-95, 2012.
T. Winhusen, Brady, K. T., Stitzer, M., Woody, G., Lindblad, R., Kropp, F., Brigham, G., Liu, D., Sparenborg, S., Sharma, G., VanVeldhuisen, P., Adinoff, B., and Somoza, E., “Evaluation of buspirone for relapse-prevention in adults with cocaine dependence: an efficacy trial conducted in the real world.”, Contemp Clin Trials, vol. 33, no. 5, pp. 993-1002, 2012.
2010
M. A. Kominiarek, VanVeldhuisen, P., Hibbard, J., Landy, H., Haberman, S., Learman, L., Wilkins, I., Bailit, J., Branch, W., Burkman, R., Gonzalez-Quintero, V. Hugo, Gregory, K., Hatjis, C., Hoffman, M., Ramirez, M., Reddy, U. M., Troendle, J., and Zhang, J., “The maternal body mass index: a strong association with delivery route.”, Am J Obstet Gynecol, vol. 203, no. 3, pp. 264.e1-7, 2010.
J. U. Hibbard, Wilkins, I., Sun, L., Gregory, K., Haberman, S., Hoffman, M., Kominiarek, M. A., Reddy, U., Bailit, J., D Branch, W., Burkman, R., Quintero, V. Hugo Gonza, Hatjis, C. G., Landy, H., Ramirez, M., VanVeldhuisen, P., Troendle, J., and Zhang, J., “Respiratory morbidity in late preterm births.”, JAMA, vol. 304, no. 4, pp. 419-25, 2010.
2008
M. Frogel, Nerwen, C., Boron, M., Cohen, A., VanVeldhuisen, P., Harrington, M., and Groothuis, J., “Improved outcomes with home-based administration of palivizumab: results from the 2000-2004 Palivizumab Outcomes Registry.”, Pediatr Infect Dis J, vol. 27, no. 10, pp. 870-3, 2008.
2003
T. Gonwa, Johnson, C., Ahsan, N., Alfrey, E. J., Halloran, P., Stegall, M., Hardy, M., Metzger, R., Shield, C., Rocher, L., Scandling, J., Sorensen, J., Mulloy, L., Light, J., Corwin, C., Danovitch, G., Wachs, M., VanVeldhuisen, P., Leonhardt, M., and Fitzsimmons, W. E., “Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.”, Transplantation, vol. 75, no. 12, pp. 2048-53, 2003.
A. Krupnick Freeman, Linowski, G. J., Brady, C., Lind, L., VanVeldhuisen, P., Singer, G., and Lebwohl, M., “Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas.”, J Am Acad Dermatol, vol. 48, no. 4, pp. 564-8, 2003.